Health
Cyberattack on UnitedHealth Leaves Medical Providers in Debt
Two independent medical practices in Minnesota once hoped to expand operations but have spent the past year struggling to recover from the cyberattack on a vast UnitedHealth Group payment system.
Odom Health & Wellness, a sports medicine and rehabilitation outfit, and the Dillman Clinic & Lab, a family medicine practice, are among the thousands of medical offices that experienced sudden financial turmoil last year. The cyberattack against Change Healthcare, a division of United, paralyzed much of the nation’s health-care payment system for months.
Change lent billions of dollars to medical practices that were short on cash but has begun demanding repayments.
Dillman and Odom are suing United in U.S. District Court in Minneapolis, accusing the corporation of negligence related to the cyberattack and claiming they sustained excessive expenses because of the attack’s fallout.
In addition, Odom and Dillman asserted in court filings that the company’s insurance arm, UnitedHealthcare, has in turn been denying claims to cover patient care for being submitted late.
Lawmakers viewed the chaos caused by the cyberattack as a result of United’s seemingly insatiable desire to buy up companies like Change, alongside doctors’ practices and pharmacy businesses. The widespread disruption was a reminder of how deeply United’s sprawling subsidiaries had become embedded in the nation’s health care system.
“This is yet another sign that the rapid consolidation of major health care companies has harmed, rather than helped, American patients and doctors,” Senator Ron Wyden, Democrat of Oregon, said of the financial bind that the cyberattack had placed on practices.
Last month, the American Medical Association sent a letter to Optum, the UnitedHealth division that owns Change, saying that it was concerned that many practices were being pressured to repay loans despite continued financial difficulties from the cyberattack.
Since March 2024, Change had provided $9 billion in interest-free loans to more than 10,000 medical providers, including $569,680 to Odom and $157,600 to Dillman.
A year later, roughly $5.5 billion had been repaid, United said in court filings. About 3,500 practices, including Odom, Dillman and six other plaintiffs in the lawsuits, had made no repayments as of April 1. Several other practices and patients have also filed suits against United.
In a statement, Change said it would “continue to actively work with providers to identify flexible repayment plans based on the individual circumstances of providers and their practices.”
It added, “We have also worked with UnitedHealthcare to ensure the claims it receives are reviewed in light of the challenges providers experienced, including waiving timely filing requirements for the plans under its control.”
Change compared its efforts to recoup loans to those by the Centers for Medicare and Medicaid Services. After the cyberattack, C.M.S. provided accelerated payments to practices to cover Medicare billings delayed by the cyberattack. It has since garnished Medicare claims to recoup the funds.
In court filings, United cited data showing that only a small percentage of Odom’s and Dillman’s health care claims were rejected for being “untimely,” although those denials increased after the cyberattack.
Calling the plaintiffs’ motions a “collective shakedown,” UnitedHealth has also requested that the district court reject their request for an injunction against repayment of loans, arguing that they did not have the right to interfere in its business with thousands of other loan recipients.
An injunction, United argued, could be used by other medical practices to “hold hostage billions of dollars.”
Dr. Megan Dillman, who specializes in pediatrics and internal medicine, said she had opened her Lakeville, Minn., practice in 2022 to “bring the joy back to medicine.” She said she spent far more time with patients than the spartan 15 minutes that corporate health care operations have increasingly required of their doctors.
“I have some patients where I don’t think they would be here today if we didn’t exist,” Dr. Dillman said, citing cancers she had detected that had been missed by more hurried doctors.
Her husband, Richard Dillman, runs the business side of the practice. He called United’s repayment demands “a kick in the teeth.”
“I’d rather go through the Special Forces qualification course back to back — to back to back — than ever do this again,” said Mr. Dillman, a former Green Beret.
At the time of the cyberattack, Change’s medical-billing clearinghouse processed about 45 percent of the nation’s health care transactions, or about $2 trillion annually. The company had to take its services offline in February 2024 to contain damage from the attack, halting much of the health care system’s cash flow and unleashing chaos.
The associated breach of private information was the largest reported in U.S. health-care history. In January, United increased the reported number of people whose personal data had been exposed to 190 million from 100 million.
The U.S. Department of Health and Human Services’s Office of Civil Rights opened an investigation into the ransomware attack in March 2024. An agency spokesperson stated that it “does not generally comment on current or open investigations.” Some health care companies have been fined for breaches involving patient data.
Company officials have said that the hackers infiltrated Change’s systems by obtaining compromised login credentials and using a portal for entry that did not require multifactor authentication.
United officials confirmed that the company had paid a $22 million ransom to the Russian cybercriminals who claimed responsibility. The corporation reported in a January earnings report that the cyberattack had by then cost $3.1 billion.
Health care reimbursements didn’t begin to channel relatively freely through Change until June 2024, although United said that some of its systems had taken longer to come back online and that a few were still not at 100 percent.
At congressional hearings in May 2024, senators slammed Andrew Witty, United’s chief executive, for how the company had handled the cyberattack and the disruption it caused thousands of providers. Mr. Witty testified that the company had “no intention of asking for repayment until providers determine their business is back to normal.”
The loan terms stipulated that Change would not demand repayment until “after claims processing and/or payment processing services and payments impacted during the service disruption period are being processed.”
The meaning of “being processed” is now at the center of the court cases.
Change began seeking repayment from Dillman and Odom through what the medical practices characterized in court filings as a succession of increasingly aggressive letters. Both practices told Change they were unable to repay and neither accepted repayment plan offers. Change then in January demanded full repayment and threatened to withhold future reimbursements for patients’ health care.
“It’s disappointing but not surprising that UnitedHealth Group has decided to prioritize its bottom line over the well-being of families and small businesses,” said Mr. Wyden, who led the Senate hearing on the cyberattack.
The A.M.A. called upon the company to negotiate “an individualized, realistic repayment plan” with each practice.
Dr. Catherine Mazzola, who runs a pediatric neurology and neurosurgery practice in New Jersey, is among many others who have also battled with United over the loans.
“Optum, in my opinion, is acting like a loan shark trying to rapidly collect,” Dr. Mazzola, who is not a plaintiff in the lawsuits against United, said of the division that owns Change.
Dr. Mazzola received a $535,000 loan, and she said she had later told Change she could not repay it. She proposed a schedule but received no response. So she began paying $10,000 a month in January. But without any warning, she said, United began garnishing her reimbursements.
A United spokesman disputed her account, saying demand for full repayment would not occur without warning but after months of efforts to negotiate a plan.
Today, Dr. Odom employs about 110 people, many of whom provide rehab to older people in assisted-living facilities. If his practice had to repay the Change loan immediately, his lawsuit asserted, he would have to lay off at least 22 staff members. Dr. Odom said that could prompt assisted-living chains to drop his services and cause more financial harm.
“We face an uphill battle as such a small company,” said Dr. Meghan Klein, Odom’s president. Speaking to the gulf between her company’s finances and United’s, she said: “What is little impact to them is huge impact to us. These are a lot of people’s lives that we’re worried about.”
The Dillman Clinic, which derives about one-quarter of its income from United insurance reimbursements, would face bankruptcy if forced to fully repay its loan, according to its lawsuit.
Having leveraged their house, their cars and their retirement accounts against their practice, the Dillmans would lose all of their assets to bankruptcy, including their home, they said.
“Part of the goal of being here is to have control over my schedule,” Dr. Dillman said. But the cyberattack-driven chaos has consumed the couple’s time, leaving little for their 6-year-old daughter.
“There are days I see her for an hour,” Dr. Dillman said. “I’m missing her childhood.”
Health
Guava for Weight Loss Is a Real Thing—Here’s the Juicy Truth
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Single workout cuts cravings, offering new hope for smokers trying to quit
NEWYou can now listen to Fox News articles!
If you’re trying to quit smoking, try a brisk walk or bike ride to curb your craving for a cigarette.
Researchers found that just one workout can reduce the urge to light up. But the type of exercise you do and how you do it makes a big difference.
High-intensity, aerobic exercise is most effective at reducing people’s cigarette cravings, a review of 59 randomized controlled trials involving more than 9,000 adults found.
FITNESS EXPERT REVEALS SIMPLE RULE TO GET IN SHAPE WITHOUT DREADING THE GYM: ‘JUST MOVE’
“Single-bout exercise reduced acute cravings immediately and up to 30 minutes post-exercise, but not longer-term cravings,” the authors of the study, published in the Journal of Sport and Health Science, reported.
Aerobic exercise is the most effective form of exercise for reducing cravings for cigarettes, researchers found. (iStock)
The research team highlighted other key findings from their study of “exercise-based interventions for smoking cessation.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Exercise training made people between 15% and 21% more likely to abstain from smoking than those who didn’t exercise, the authors found.
Researchers found that exercise curbs people’s cigarette cravings for up to 30 minutes after they stop exercising. (iStock)
Regular exercise also caused smokers to cut back by an average of two cigarettes per day.
In addition to being a free and accessible method for reducing smoking, exercise is also effective at reducing anxiety and stress, which drive many people to smoke.
CLICK HERE FOR MORE LIFESTYLE STORIES
The authors suggest that because exercise boosts feel-good hormones, such as dopamine, and reduces the stress hormone cortisol, smokers who work out feel less inclined to use nicotine as a brain reward.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Exercise should be integrated into other smoking cessation programs to enhance quit success, the authors concluded.
Exercise releases similar feel-good brain chemicals that people get from cigarettes, researchers suggested. (iStock)
They also noted that none of the trials addressed vaping and recommended that future research target the use of electronic cigarettes.
Health
Hantavirus Vaccines and Treatments Are in the Pipeline
The deadly hantavirus outbreak aboard the cruise ship MV Hondius has put the spotlight on a rare pathogen that typically attracts relatively little attention, even from scientists.
There are no targeted treatments for hantaviruses, which are typically carried by rodents, and no widely available vaccines. So when passengers began falling ill in the middle of the Atlantic Ocean, doctors and public health experts were limited in what they could offer.
“It’s kind of a wake-up call,” said Dr. Vaithi Arumugaswami, an infectious disease researcher at the University of California, Los Angeles. “Our tool kit is almost empty.”
That’s not for lack of trying. A handful of scientific teams around the world have been working — for decades, in some cases — to develop hantavirus treatments and vaccines. But it has not been easy to find funding or nurture commercial interest in medical interventions for a type of pathogen that does not infect humans often and does not spread easily between people.
“It’s not an airborne, highly contagious viral threat, so it hasn’t been as high a priority for groups trying to prevent pandemics,” said Jay Hooper, a virologist at the United States Army Medical Research Institute of Infectious Diseases.
But there are promising vaccines and treatments in development. And some of them, experts said, could be moved through the pipeline rapidly if hantavirus interventions became a priority.
“I do think there are things that are sitting there on the bench that could be quickly developed,” said Dr. Ronald Nahass, the president of the Infectious Diseases Society of America. “But nothing is ready.”
Vaccine development
There are two main types of hantaviruses: Old World viruses, which circulate primarily in Asia and Europe, and New World viruses, which are found in the Americas. The cruise ship outbreak has been linked to a New World virus known as the Andes virus, which is endemic to South America and is the only hantavirus known to spread between people.
There are vaccines that target some of the Old World viruses in Asia, but their efficacy is modest, experts said. And there are no licensed vaccines for the New World viruses, which include the Sin Nombre virus endemic to rodents in the western United States.
But there are some in development. Dr. Hooper and his colleagues have developed a DNA vaccine for the Andes virus, which proved promising in a small phase 1 trial. Under certain dosing regimens, the researchers found, more than 80 percent of participants produced neutralizing antibodies. “It’s pretty amazing,” said Dr. Hooper, who is an inventor on multiple hantavirus vaccine patents owned by the U.S. government. “Getting these kinds of neutralizing antibodies in humans is impressive.”
There were drawbacks, including that the vaccine seemed to require at least three doses. But the vaccine is ready for further development “if there’s a need,” Dr. Hooper said. “We’ve done the science. It’s just other forces that are required to move vaccines forward — markets, government demand.”
Other teams have potential vaccines in earlier stages of development. For instance, Bryce Warner, a hantavirus researcher at the University of Saskatchewan, and his colleagues are exploring a variety of approaches, including a nasal vaccine that they hope might spark a more robust immune response in the airway.
But the research, which is being conducted in hamsters, is still in early stages, and hantavirus vaccine candidates can be challenging to move forward. Scientists lack good large-animal models for hantaviruses, Dr. Warner said, and human cases are rare enough to make trials tricky. “It’s very difficult to conduct a clinical trial when you only have a limited number of cases annually,” he said. “You don’t have the numbers of people to really show a robust effect.”
Drug hunting
Currently, the primary treatment for hantavirus infection is supportive care, which may include supplemental oxygen or heart-lung bypass machines. Doctors also sometimes prescribe an existing antiviral drug, called ribavirin, but there is not strong evidence that it is effective for New World viruses, scientists said.
The hunt for new drugs is underway, though. At U.C.L.A., Dr. Arumugaswami and his colleagues found that favipiravir, an antiviral approved to treat influenza in Japan, inhibited the Andes virus in human cells. They also identified several compounds that had broad antiviral activity, blocking hantaviruses as well as other types of viruses, in human organoids, miniature clusters of tissue that mimic the function of organs.
Other teams have been working to develop therapeutic antibody treatments, often working from blood samples collected from hantavirus survivors. “We were able to isolate the natural antibodies that people are making and basically winnow them down and find one that was really good,” said Kartik Chandran, a virologist at the Albert Einstein College of Medicine in New York. “We actually found several.”
When Dr. Chandran and his colleagues tested these antibodies in hamsters, one produced especially encouraging results: It seemed to work against both Old and New World hantaviruses and was effective even when given relatively late in the course of infection, Dr. Chandran said.
(Dr. Chandran is listed as an inventor on patents for hantavirus antibodies.)
Several other teams have also produced antibodies that were broadly effective in small animals, but that is where a number of potential products have stalled, experts said.
“We have a lead drug, and now what we need is someone to pay the money, which would be something like $40 million, to go the next step,” said Dr. James Crowe, director of the Vanderbilt Center for Antibody Therapeutics. “We have neither government nor foundation nor company support to do that. So we’re just waiting to find a partner.”
(Vanderbilt University has applied for patents related to these antibodies; Dr. Crowe is listed as the inventor.)
Experts said that they hoped the current outbreak might help bring attention to a family of often-overlooked viruses.
“Certainly judging by just my inbox and text messages, there’s a renewed interest in these agents, and renewed interest in maybe at least revisiting where they are in the priority list,” Dr. Chandran said.
Whether that interest can be sustained after the virus fades from the headlines remains to be seen, experts acknowledged.
“Raising awareness never hurts,” Dr. Warner said. “We’ll see whether or not it leads to anything tangible, at least in terms of funding and resources for advancing some of these things that are lacking for hantavirus.”
-
Massachusetts4 minutes agoThe Massachusetts beach towns better than Cape Cod, per Condé Nast
-
Minnesota10 minutes agoGame Four Preview: San Antonio Spurs vs. Minnesota Timberwolves
-
Mississippi16 minutes agoRyan McPherson injury update, Mississippi State star hurts ankle, exits Auburn game
-
Missouri22 minutes ago
Missouri Lottery Powerball, Pick 3 winning numbers for May 9, 2026
-
Montana28 minutes agoMontana Vista residents question impacts of proposed Pecos West energy project
-
Nebraska34 minutes ago
Nebraska Lottery results: See winning numbers for Powerball, Pick 3 on May 9, 2026
-
Nevada40 minutes ago“We lost a true champion”: Educators, lawmakers remember Joyce Woodhause’s legacy after her death
-
New Hampshire46 minutes agoFAA Employee Accused Of Threatening Trump | Teen Reported Missing | Summer Forecast | More: Nearby News NH